Periode bali modal bisnis Talis Biomedical Corp. (TLIS)

Lambang korporat lan logo Talis Biomedical Corp (TLIS)

Talis Biomedical (TLIS) develops rapid tests by outsourcing the assembly of Talis One analyzers through US contractors. This price chart on GURU.Markets with the -0.20 indicator confirms the current trend. However, sanctions and disruptions in Asian electronics supplies are increasing production costs. The company is currently in a financial crisis, liquidating assets and shutting down development projects amid depleting capital.

TLIS: Pangali P/E Talis Biomedical Corporation 04.07.2022 - 07.09.2024
Produk mawa merek Talis Biomedical

The P/E ratio is calculated as the ratio of current market capitalization to the company's net income. This metric determines the cost of one dollar of profit, reflecting market expectations for business growth rates. For Talis Biomedical (TLIS), this indicator loses its classical meaning due to the complete cessation of commercial activities and R&D. The absence of operational development renders the company's fundamental P/E an indicator of speculative sentiment. Analyzing this chart helps identify overpayment for non-performing assets.